BACKGROUND: Following the broad application of new analytical methods, more and more pathophysiological processes in previously unknown diseases have been elucidated. The spectrum of clinical presentation of rare inherited metabolic diseases (IMDs) is broad and ranges from single organ involvement to multisystemic diseases. With the aim of overcoming the limited knowledge about the natural course, current diagnostic and therapeutic approaches, the project has established the first unified patient registry for IMDs that fully meets the requirements of the European Infrastructure for Rare Diseases (ERDRI). RESULTS: In collaboration with the European Reference Network for Rare Hereditary Metabolic Disorders (MetabERN), the Unified European registry for Inherited Metabolic Diseases (U-IMD) was established to collect patient data as an observational, non-interventional natural history study. Following the recommendations of the ERDRI the U-IMD registry uses common data elements to define the IMDs, report the clinical phenotype, describe the biochemical markers and to capture the drug treatment. Until today, more than 1100 IMD patients have been registered. CONCLUSION: The U-IMD registry is the first observational, non-interventional patient registry that encompasses all known IMDs. Full semantic interoperability for other registries has been achieved, as demonstrated by the use of a minimum common core data set for equivalent description of metabolic patients in U-IMD and in the patient registry of the European Rare Kidney Disease Reference Network (ERKNet). In conclusion, the U-IMD registry will contribute to a better understanding of the long-term course of IMDs and improved patients care by understanding the natural disease course and by enabling an optimization of diagnostic and therapeutic strategies.

Department of Pediatrics and Inherited Metabolic Disorders Charles University 1st Faculty of Medicine and General University Hospital Prague Czech Republic

Division of Neuropediatrics and Metabolic Medicine Department of General Pediatrics Centre for Child and Adolescent Medicine Im Neuenheimer Feld 430 69120 Heidelberg Germany

Division of Pediatric Nephrology Department of General Pediatrics Centre for Child and Adolescent Medicine Heidelberg Germany

Inborn Errors of Metabolism Unit Neurology Department Institut de Recerca Sant Joan de Déu and CIBERER ISCIII Barcelona Spain

Regional Coordinating Center for Rare Diseases Udine University Hospital Udine Italy

U O C di Patologia Metabolica Dipartimento di Medicina Pediatrica IRCCS Ospedale Pediatrico Bambino Gesù Rome Italy

000      

00000naa a2200000 a 4500

001      

bmc21019221

003      

CZ-PrNML

005      

20210830100804.0

007      

ta

008      

210728s2021 xxk f 000 0|eng||

009      

AR

024    7_

$a 10.1186/s13023-021-01726-3 $2 doi

035    __

$a (PubMed)33602304

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxk

100    1_

$a Opladen, Thomas $u Division of Neuropediatrics and Metabolic Medicine, Department of General Pediatrics, Centre for Child and Adolescent Medicine, Im Neuenheimer Feld 430, 69120, Heidelberg, Germany. thomas.opladen@med.uni-heidelberg.de

245    10

$a U-IMD: the first Unified European registry for inherited metabolic diseases / $c T. Opladen, F. Gleich, V. Kozich, M. Scarpa, D. Martinelli, F. Schaefer, K. Jeltsch, N. Juliá-Palacios, Á. García-Cazorla, C. Dionisi-Vici, S. Kölker

520    9_

$a BACKGROUND: Following the broad application of new analytical methods, more and more pathophysiological processes in previously unknown diseases have been elucidated. The spectrum of clinical presentation of rare inherited metabolic diseases (IMDs) is broad and ranges from single organ involvement to multisystemic diseases. With the aim of overcoming the limited knowledge about the natural course, current diagnostic and therapeutic approaches, the project has established the first unified patient registry for IMDs that fully meets the requirements of the European Infrastructure for Rare Diseases (ERDRI). RESULTS: In collaboration with the European Reference Network for Rare Hereditary Metabolic Disorders (MetabERN), the Unified European registry for Inherited Metabolic Diseases (U-IMD) was established to collect patient data as an observational, non-interventional natural history study. Following the recommendations of the ERDRI the U-IMD registry uses common data elements to define the IMDs, report the clinical phenotype, describe the biochemical markers and to capture the drug treatment. Until today, more than 1100 IMD patients have been registered. CONCLUSION: The U-IMD registry is the first observational, non-interventional patient registry that encompasses all known IMDs. Full semantic interoperability for other registries has been achieved, as demonstrated by the use of a minimum common core data set for equivalent description of metabolic patients in U-IMD and in the patient registry of the European Rare Kidney Disease Reference Network (ERKNet). In conclusion, the U-IMD registry will contribute to a better understanding of the long-term course of IMDs and improved patients care by understanding the natural disease course and by enabling an optimization of diagnostic and therapeutic strategies.

650    _2

$a lidé $7 D006801

650    12

$a metabolické nemoci $x genetika $7 D008659

650    _2

$a vzácné nemoci $x genetika $7 D035583

650    _2

$a registrace $7 D012042

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Gleich, Florian $u Division of Neuropediatrics and Metabolic Medicine, Department of General Pediatrics, Centre for Child and Adolescent Medicine, Im Neuenheimer Feld 430, 69120, Heidelberg, Germany

700    1_

$a Kozich, Viktor $u Department of Pediatrics and Inherited Metabolic Disorders, Charles University - First Faculty of Medicine and General University Hospital, Prague, Czech Republic

700    1_

$a Scarpa, Maurizio $u Regional Coordinating Center for Rare Diseases, Udine University Hospital, Udine, Italy

700    1_

$a Martinelli, Diego $u U.O.C. di Patologia Metabolica, Dipartimento di Medicina Pediatrica, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy

700    1_

$a Schaefer, Franz $u Division of Pediatric Nephrology, Department of General Pediatrics, Centre for Child and Adolescent Medicine, Heidelberg, Germany

700    1_

$a Jeltsch, Kathrin $u Division of Neuropediatrics and Metabolic Medicine, Department of General Pediatrics, Centre for Child and Adolescent Medicine, Im Neuenheimer Feld 430, 69120, Heidelberg, Germany

700    1_

$a Juliá-Palacios, Natalia $u Inborn Errors of Metabolism Unit, Neurology Department, Institut de Recerca Sant Joan de Déu, and CIBERER-ISCIII, Barcelona, Spain

700    1_

$a García-Cazorla, Ángels $u Inborn Errors of Metabolism Unit, Neurology Department, Institut de Recerca Sant Joan de Déu, and CIBERER-ISCIII, Barcelona, Spain

700    1_

$a Dionisi-Vici, Carlo $u U.O.C. di Patologia Metabolica, Dipartimento di Medicina Pediatrica, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy

700    1_

$a Kölker, Stefan $u Division of Neuropediatrics and Metabolic Medicine, Department of General Pediatrics, Centre for Child and Adolescent Medicine, Im Neuenheimer Feld 430, 69120, Heidelberg, Germany

773    0_

$w MED00165365 $t Orphanet journal of rare diseases $x 1750-1172 $g Roč. 16, č. 1 (2021), s. 95

856    41

$u https://pubmed.ncbi.nlm.nih.gov/33602304 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y p $z 0

990    __

$a 20210728 $b ABA008

991    __

$a 20210830100804 $b ABA008

999    __

$a ok $b bmc $g 1690118 $s 1139667

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2021 $b 16 $c 1 $d 95 $e 20210218 $i 1750-1172 $m Orphanet journal of rare diseases $n Orphanet J Rare Dis $x MED00165365

LZP    __

$a Pubmed-20210728